BF Biosciences gains DRAP's approval for brownfield expansion

By MG News | September 09, 2024 at 11:49 AM GMT+05:00

0:00

September 09, 2024 (MLN): BF Biosciences Limited, a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ), has secured approval from the Drug Regulatory Authority of Pakistan (DRAP) for its brownfield expansion (Line II).

This expansion includes a pre-filled syringes line, a liquid and lyophilized line, and a product development section.

The commercial production from the pre-filled syringes line has commenced, whereas the liquid & lyophilized line is under internal validation and will start commercial production in the second quarter of FY 2024-25.

Additionally, BF Biosciences Limited has launched Sematide (Semaglutide) in a pre-filled syringe.

Sematide is the first Glucagon-Like Peptide 1 (GLP1) receptor agonist approved for local manufacture in Pakistan, offering a convenient solution for diabetes management.

The pre-filled syringe eliminates dosing errors and is easy to use by the patients.

Sematide is being manufactured at the new state-of-the-art European prefilled syringes line of BF Biosciences Limited.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	124,379.07 220.31M	1.91% 2332.60
ALLSHR	77,679.82 768.94M	1.80% 1376.61
KSE30	37,915.73 105.69M	1.92% 713.35
KMI30	184,872.78 113.74M	1.90% 3446.47
KMIALLSHR	53,473.19 418.85M	1.75% 921.24
BKTi	31,363.74 21.26M	1.66% 510.82
OGTi	27,886.19 21.80M	1.53% 419.75

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	107,740.00	108,580.00 107,050.00	-535.00 -0.49%
BRENT CRUDE	67.31	68.42 67.20	-0.42 -0.62%
RICHARDS BAY COAL MONTHLY	88.00	0.00 0.00	-2.90 -3.19%
ROTTERDAM COAL MONTHLY	103.90	0.00 0.00	0.20 0.19%
USD RBD PALM OLEIN	998.50	998.50 998.50	0.00 0.00%
CRUDE OIL - WTI	65.07	66.09 64.80	-0.17 -0.26%
SUGAR #11 WORLD	16.69	16.80 16.39	0.27 1.64%